Nederlands English
SEPTEMBER 27 TO
OCTOBER 6 2024
SEPTEMBER 27 TO
OCTOBER 6 2024
Go back

Rob Ruijtenbeek

Rob Ruijtenbeek, Vice President, Head Antibody Discovery Technologies Genmab.